Beyond Glioma: The Utility of Radiomic Analysis for Non-Glial Intracranial Tumors

Diffusion-weighted imaging-based radiomics model using automatic machine learning to differentiate cerebral cystic metastases from brain abscesses

OBJECTIVES

To develop a radiomics model based on diffusion-weighted imaging (DWI) utilizing automated machine learning method to differentiate cerebral cystic metastases from brain abscesses.

MATERIALS AND METHODS

A total of 186 patients with cerebral cystic metastases (n = 98) and brain abscesses (n = 88) from two clinical institutions were retrospectively included. The datasets (129 from institution A) were randomly portioned into separate 75% training and 25% internal testing sets. Radiomics features were extracted from DWI images using two subregions of the lesion (cystic core and solid wall). A thorough image preprocessing method was applied to DWI images to ensure the robustness of radiomics features before feature extraction. Then the Tree-based Pipeline Optimization Tool (TPOT) was utilized to search for the best optimized machine learning pipeline, using a fivefold cross-validation in the training set. The external test set (57 from institution B) was used to evaluate the model's performance.

RESULTS

Seven distinct TPOT models were optimized to distinguish between cerebral cystic metastases and abscesses either based on different features combination or using wavelet transform. The optimal model demonstrated an AUC of 1.00, an accuracy of 0.97, sensitivity of 1.00, and specificity of 0.93 in the internal test set, based on the combination of cystic core and solid wall radiomics signature using wavelet transform. In the external test set, this model reached 1.00 AUC, 0.96 accuracy, 1.00 sensitivity, and 0.93 specificity.

CONCLUSION

The DWI-based radiomics model established by TPOT exhibits a promising predictive capacity in distinguishing cerebral cystic metastases from abscesses.

Natural language processing deep learning models for the differential between high-grade gliomas and metastasis: what if the key is how we report them?

OBJECTIVES

The differential between high-grade glioma (HGG) and metastasis remains challenging in common radiological practice. We compare different natural language processing (NLP)-based deep learning models to assist radiologists based on data contained in radiology reports.

METHODS

This retrospective study included 185 MRI reports between 2010 and 2022 from two different institutions. A total of 117 reports were used for the training and 21 were reserved for the validation set, while the rest were used as a test set. A comparison of the performance of different deep learning models for HGG and metastasis classification has been carried out. Specifically, Convolutional Neural Network (CNN), Bidirectional Long Short-Term Memory (BiLSTM), a hybrid version of BiLSTM and CNN, and a radiology-specific Bidirectional Encoder Representations from Transformers (RadBERT) model were used.

RESULTS

For the classification of MRI reports, the CNN network provided the best results among all tested, showing a macro-avg precision of 87.32%, a sensitivity of 87.45%, and an F1 score of 87.23%. In addition, our NLP algorithm detected keywords such as tumor, temporal, and lobe to positively classify a radiological report as HGG or metastasis group.

CONCLUSIONS

A deep learning model based on CNN enables radiologists to discriminate between HGG and metastasis based on MRI reports with high-precision values. This approach should be considered an additional tool in diagnosing these central nervous system lesions.

CLINICAL RELEVANCE STATEMENT

The use of our NLP model enables radiologists to differentiate between patients with high-grade glioma and metastasis based on their MRI reports and can be used as an additional tool to the conventional image-based approach for this challenging task.

KEY POINTS

• Differential between high-grade glioma and metastasis is still challenging in common radiological practice. • Natural language processing (NLP)-based deep learning models can assist radiologists based on data contained in radiology reports. • We have developed and tested a natural language processing model for discriminating between high-grade glioma and metastasis based on MRI reports that show high precision for this task.

Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies

Primary brain tumors are a leading cause of death worldwide and are characterized by extraordinary heterogeneity and high invasiveness. Current drug and radiotherapy therapies combined with surgical approaches tend to increase the five-year survival of affected patients, however, the overall mortality rate remains high, thus constituting a clinical challenge for which the discovery of new therapeutic strategies is needed. In this field, novel immunotherapy approaches, aimed at overcoming the complex immunosuppressive microenvironment, could represent a new method of treatment for central nervous system (CNS) tumors. Chemokines especially are a well-defined group of proteins that were so named due to their chemotactic properties of binding their receptors. Chemokines regulate the recruitment and/or tissue retention of immune cells as well as the mobilization of tumor cells that have undergone epithelial–mesenchymal transition, promoting tumor growth. On this basis, this review focuses on the function and involvement of chemokines and their receptors in primary brain tumors, specifically examining chemokine-targeting immunotherapies as one of the most promising strategies in neuro-oncology.